NewCode Oncology

NewCode Oncology has developed an AI-enabled, RNA-Seq based universal tumour classifier with utility in drug development and diagnostics. The company is pursuing sarcoma as the first entry-point to market, targeting clinical trial partnerships while developing a clinical diagnostic and decision support tool.